Efficacy and safety of alogliptin in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, dose-ranging comparison with placebo, followed by a long-term extension study

By Seino Yutaka   Fujita Tetsuya   Hiroi Shinzo   Hirayama Masashi   Kaku Kohei  

Current Medical Research and Opinion, Vol. 27, Iss. 9, 2011-09 ,pp. : 1781-1792

Informa Healthcare

Access to resources Recommend Favorite

Long-term effects of pioglitazone in Japanese patients with type 2 diabetes without a recent history of macrovascular morbidity

By Kaku Kohei   Daida Hiroyuki   Kashiwagi Atsunori   Yamashina Akira   Yamazaki Tsutomu   Momomura Shin-ichi   Iwase Takashi   Yamasaki Yoshimitsu   Nagatsuka Kazuyuki   Kitagawa Kazuo   Kawamori Ryuzo  

Current Medical Research and Opinion, Vol. 25, Iss. 12, 2009-12 ,pp. : 2925-2932

Informa Healthcare

Access to resources Recommend Favorite

Effects of Rehabilitation Programmes for Patients on Long-term Sick Leave for Burnout: a 3-Year Follow-up of the Rest Study

By Stenlund Therese   Nordin Maria   Järvholm Lisbeth Slunga  

Journal of Rehabilitation Medicine, Vol. 44, Iss. 8, 2012-07 ,pp. : 684-690

Medical Journals Limited

Access to resources Recommend Favorite

Long‐term glycaemic response and tolerability of dapagliflozin versus a sulphonylurea as add‐on therapy to metformin in patients with type 2 diabetes: 4‐year data

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 17, Iss. 6, 2015-06 ,pp. : 581-590

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long‐term effectiveness of a community‐based model of care in Māori and Pacific patients with type 2 diabetes and chronic kidney disease: a 4‐year follow up of the DElay Future End Stage Nephropathy due to Diabetes (DEFEND) study

By  

INTERNAL MEDICINE JOURNAL, Vol. 45, Iss. 8, 2015-08 ,pp. : 843-849

John Wiley & Sons Inc

Access to resources Recommend Favorite